Biotechnological Progress: Opportunities For Tomorrow’s Medicine
Health is the foundation for quality of life, performance, and well-being. The experts at VDI/VDE-IT are well versed in the most important issues for tomorrow’s health. A primary example being biotechnology, one of the key forces driving innovation in healthcare. From new methods such as CRISPR-Cas gene editing to tailor-made therapies, biotechnological approaches are opening up many new possibilities for earlier detection of diseases, more targeted prevention and treatment, and more efficient healthcare overall.
Personalised Medicine for Effective Therapies
One particularly dynamic field is personalised medicine. Rather than relying on a “one-size-fits-all” approach, new technologies enable treatment that is tailored to the genetic and biological characteristics of each individual.
In practice, this means that a cancer drug is only administered to those patients for whom it is likely to be highly effective. This increases the chances of success of a therapy and reduces side effects.
A key technology in this context is the CRISPR-Cas gene editing tool. It can be used to make targeted changes to our DNA, our genetic material, similar to a precise correction function in a text. This opens up the possibility of treating genetic disorders directly at their source, including conditions such as ALS or Huntington’s disease, which are often caused by errors in the DNA.
The concept of “organ on a chip” takes a different approach. Tiny organ models are replicated on microchips to mimic the function of human organs as realistically as possible. In the future, these chips may allow new medicines to be tested with fewer animal experiments, whiles helping to predict the effectiveness of therapies. This accelerates development and increases safety for patients.